Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer
Pancreatic cancer is one of the leading causes of cancer-related mortality in both developed and developing countries. The incidence of pancreatic cancer in China accounts for about a quater of the global incidence, and the epidemiological characteristics and therapeutic strategies differ due to soc...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Journal of the National Cancer Center |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667005422000618 |
| _version_ | 1797987650211151872 |
|---|---|
| author | Jiujie Cui Feng Jiao Qi Li Zheng Wang Deliang Fu Jun Liang Houjie Liang Tingyi Xia Tao Zhang Yang Zhang Guanghai Dai Zhihong Zhang Jian Wang Yongrui Bai Yuxian Bai Feng Bi Donghui Chen Dan Cao Jie Chen Weijia Fang Yong Gao Jianwei Guo Jihui Hao Haiqing Hua Xinyu Huang Wenchao Liu Xiufeng Liu Da Li Ji Li Enxiao Li Zhiwei Li Hongming Pan Lin Shen Yongwei Sun Min Tao Chengfeng Wang Fenghua Wang Jianping Xiong Taiping Zhang Xuebin Zhang Xianbao Zhan Leizhen Zheng Gang Ren Tingting Zhang Jun Zhou Qingyong Ma Shukui Qin Chunyi Hao Liwei Wang |
| author_facet | Jiujie Cui Feng Jiao Qi Li Zheng Wang Deliang Fu Jun Liang Houjie Liang Tingyi Xia Tao Zhang Yang Zhang Guanghai Dai Zhihong Zhang Jian Wang Yongrui Bai Yuxian Bai Feng Bi Donghui Chen Dan Cao Jie Chen Weijia Fang Yong Gao Jianwei Guo Jihui Hao Haiqing Hua Xinyu Huang Wenchao Liu Xiufeng Liu Da Li Ji Li Enxiao Li Zhiwei Li Hongming Pan Lin Shen Yongwei Sun Min Tao Chengfeng Wang Fenghua Wang Jianping Xiong Taiping Zhang Xuebin Zhang Xianbao Zhan Leizhen Zheng Gang Ren Tingting Zhang Jun Zhou Qingyong Ma Shukui Qin Chunyi Hao Liwei Wang |
| author_sort | Jiujie Cui |
| collection | DOAJ |
| description | Pancreatic cancer is one of the leading causes of cancer-related mortality in both developed and developing countries. The incidence of pancreatic cancer in China accounts for about a quater of the global incidence, and the epidemiological characteristics and therapeutic strategies differ due to social, economic, cultural, environmental, and public health factors. Non-domestic guidelines do not reflect the clinicopathologic characteristics and treatment patterns of Chinese patients. Thus, in 2018, the Chinese Society of Clinical Oncology (CSCO) organized a panel of senior experts from all sub-specialties within the field of pancreatic oncology to compile the Chinese guidelines for the diagnosis and treatment of pancreatic cancer. The guidelines were made based on both the Western and Eastern clinical evidence and updated every one or two years. The experts made consensus judgments and classified evidence-based recommendations into various grades according to the regional differences, the accessibility of diagnostic and treatment resources, and health economic indexes in China. Here we present the latest version of the guidelines, which covers the diagnosis, treatment, and follow-up of pancreatic cancer. The guidelines might standardize the diagnosis and treatment of pancreatic cancer in China and will encourage oncologists to design and conduct more clinical trials about pancreatic cancer. |
| first_indexed | 2024-04-11T07:50:28Z |
| format | Article |
| id | doaj.art-76c886fc6e8f481db6ee7626b49e89d7 |
| institution | Directory Open Access Journal |
| issn | 2667-0054 |
| language | English |
| last_indexed | 2024-04-11T07:50:28Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of the National Cancer Center |
| spelling | doaj.art-76c886fc6e8f481db6ee7626b49e89d72022-12-22T04:36:05ZengElsevierJournal of the National Cancer Center2667-00542022-12-0124205215Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancerJiujie Cui0Feng Jiao1Qi Li2Zheng Wang3Deliang Fu4Jun Liang5Houjie Liang6Tingyi Xia7Tao Zhang8Yang Zhang9Guanghai Dai10Zhihong Zhang11Jian Wang12Yongrui Bai13Yuxian Bai14Feng Bi15Donghui Chen16Dan Cao17Jie Chen18Weijia Fang19Yong Gao20Jianwei Guo21Jihui Hao22Haiqing Hua23Xinyu Huang24Wenchao Liu25Xiufeng Liu26Da Li27Ji Li28Enxiao Li29Zhiwei Li30Hongming Pan31Lin Shen32Yongwei Sun33Min Tao34Chengfeng Wang35Fenghua Wang36Jianping Xiong37Taiping Zhang38Xuebin Zhang39Xianbao Zhan40Leizhen Zheng41Gang Ren42Tingting Zhang43Jun Zhou44Qingyong Ma45Shukui Qin46Chunyi Hao47Liwei Wang48Department of Medical Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Medical Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Medical Oncology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ChinaDepartment of Pancreatic Surgery, Huashan Hospital, Pancreatic Disease Institute, Fudan University, Shanghai, ChinaDepartment of Oncology, Peking University International Hospital, Beijing, ChinaDepartment of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, ChinaBeijing Huaxia Jingfang Cancer Radiotherapy Center, Former Air Force General Hospital and PLA General Hospital, Beijing, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Oncology, Chinese PLA General Hospital, Beijing, ChinaDepartment of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Imaging, Changzheng Hospital, Naval Military Medical University, Shanghai, ChinaDepartment of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaOncology Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Medical Oncology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Medical Oncology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Medical Oncology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Medical Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Pancreatic Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, ChinaDepartment of Medical Oncology, Eastern Theater Command General Hospital, Qinhuai Medical District, Nanjing, ChinaDepartment of General Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, ChinaDepartment of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xian, ChinaDepartment of Medical Oncology, Eastern Theater Command General Hospital, Qinhuai Medical District, Nanjing, ChinaDepartment of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Pancreatic Surgery, Huashan Hospital, Pancreatic Disease Institute, Fudan University, Shanghai, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, ChinaDepartment of Biliary-Pancreatic Surgery, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, ChinaDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaState Key Lab of Molecular Oncology & Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Medical Oncology, Changhai Hospital of Shanghai, Navy Medical University, Shanghai, ChinaDepartment of Oncology, Xin Hua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaPeking University Shougang Hospital, Beijing, ChinaOncology Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, ChinaDepartment of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Corresponding authors.Department of Medical Oncology, Eastern Theater Command General Hospital, Qinhuai Medical District, Nanjing, China; Corresponding authors.Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital, Beijing, China; Corresponding authors.Department of Medical Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Corresponding authors.Pancreatic cancer is one of the leading causes of cancer-related mortality in both developed and developing countries. The incidence of pancreatic cancer in China accounts for about a quater of the global incidence, and the epidemiological characteristics and therapeutic strategies differ due to social, economic, cultural, environmental, and public health factors. Non-domestic guidelines do not reflect the clinicopathologic characteristics and treatment patterns of Chinese patients. Thus, in 2018, the Chinese Society of Clinical Oncology (CSCO) organized a panel of senior experts from all sub-specialties within the field of pancreatic oncology to compile the Chinese guidelines for the diagnosis and treatment of pancreatic cancer. The guidelines were made based on both the Western and Eastern clinical evidence and updated every one or two years. The experts made consensus judgments and classified evidence-based recommendations into various grades according to the regional differences, the accessibility of diagnostic and treatment resources, and health economic indexes in China. Here we present the latest version of the guidelines, which covers the diagnosis, treatment, and follow-up of pancreatic cancer. The guidelines might standardize the diagnosis and treatment of pancreatic cancer in China and will encourage oncologists to design and conduct more clinical trials about pancreatic cancer.http://www.sciencedirect.com/science/article/pii/S2667005422000618Pancreatic cancerChinese society of clinical oncologyGuidelinesChina |
| spellingShingle | Jiujie Cui Feng Jiao Qi Li Zheng Wang Deliang Fu Jun Liang Houjie Liang Tingyi Xia Tao Zhang Yang Zhang Guanghai Dai Zhihong Zhang Jian Wang Yongrui Bai Yuxian Bai Feng Bi Donghui Chen Dan Cao Jie Chen Weijia Fang Yong Gao Jianwei Guo Jihui Hao Haiqing Hua Xinyu Huang Wenchao Liu Xiufeng Liu Da Li Ji Li Enxiao Li Zhiwei Li Hongming Pan Lin Shen Yongwei Sun Min Tao Chengfeng Wang Fenghua Wang Jianping Xiong Taiping Zhang Xuebin Zhang Xianbao Zhan Leizhen Zheng Gang Ren Tingting Zhang Jun Zhou Qingyong Ma Shukui Qin Chunyi Hao Liwei Wang Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer Journal of the National Cancer Center Pancreatic cancer Chinese society of clinical oncology Guidelines China |
| title | Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer |
| title_full | Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer |
| title_fullStr | Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer |
| title_full_unstemmed | Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer |
| title_short | Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer |
| title_sort | chinese society of clinical oncology csco clinical guidelines for the diagnosis and treatment of pancreatic cancer |
| topic | Pancreatic cancer Chinese society of clinical oncology Guidelines China |
| url | http://www.sciencedirect.com/science/article/pii/S2667005422000618 |
| work_keys_str_mv | AT jiujiecui chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT fengjiao chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT qili chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT zhengwang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT deliangfu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT junliang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT houjieliang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT tingyixia chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT taozhang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT yangzhang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT guanghaidai chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT zhihongzhang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT jianwang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT yongruibai chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT yuxianbai chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT fengbi chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT donghuichen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT dancao chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT jiechen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT weijiafang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT yonggao chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT jianweiguo chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT jihuihao chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT haiqinghua chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT xinyuhuang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT wenchaoliu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT xiufengliu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT dali chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT jili chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT enxiaoli chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT zhiweili chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT hongmingpan chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT linshen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT yongweisun chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT mintao chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT chengfengwang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT fenghuawang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT jianpingxiong chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT taipingzhang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT xuebinzhang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT xianbaozhan chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT leizhenzheng chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT gangren chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT tingtingzhang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT junzhou chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT qingyongma chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT shukuiqin chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT chunyihao chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer AT liweiwang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofpancreaticcancer |